Oligomycin A
(Synonyms: 寡霉素A; MCH 32) 目录号 : GC16859Oligomycin A 是一种 ATP 合酶抑制剂,可抑制线粒体偶联膜上依赖 ATP 和氧化磷酸化的过程。
Cas No.:579-13-5
Sample solution is provided at 25 µL, 10mM.
Oligomycin A is an inhibitor of ATP synthase, which inhibits the process taking place on mitochondria coupling membrane that depended on ATP and oxidative phosphorylation [1].
Oligomycin A produced a concentration-dependent block of Icrac with similar characteristics, but with lower potency than oligomycin B. Fits of averaged concentration-response data to a logistic function yielded IC50 values and slope factor coefficients (respectively) of 13.5 μM and 0.85 for oligomycin A, and 2.3 μM and 0.82 for oligomycin B. A two-way analysis of variance confirmed a significantly greater inhibition by oligomycin B over the concentration range tested [2].
Oligomycin A treated Wt(widetype) mice have decreased ATP levels in the liver. Concomitantly, these mice showed an enhanced apoptosis in hepatocytes as Tg mice after LPS/GalN administration [3]. Further activation of AMPK was detected in Wt mice after treatment with oligomycin A. Collectively, these data demonstrated that UCP2 expression in hepatocytes could alter mitochondrial parameters leading to activation of AMPK [3].
References:
[1]. Jastroch M, Divakaruni AS, Mookerjee S, et al. Mitochondrial proton and electron leaks. Essays Biochemistry, 2010, 47:53-67.
[2]. Cho, J.H., M. Balasubramanyam, G. Chernaya, J.P. Gardner, A. Aviv, J.P. Reeves, P.G. Dargis, and E.P. Christian. Oligomycin inhibits storeoperated channels by a mechanism independent of its effects on mitochondrial ATP. Biochem. J. 1997.324:971-980.
[3]. Shang Y, Liu Y, Du L, Wang Y, et al. Targeted expression of uncoupling protein 2 to mouse liver increases the susceptibility to lipopolysaccharide/galactosamine-induced acute liver injury. Hepatology 2009, 50: 1204-1216
Oligomycin A 是一种 ATP 合酶抑制剂,可抑制线粒体偶联膜上依赖 ATP 和氧化磷酸化的过程[1]。
Oligomycin A 产生了 Icrac 的浓度依赖性块,具有相似的特性,但效力低于寡霉素 B。平均浓度-响应数据与逻辑函数的拟合产生 IC50 值和斜率系数(分别)为 13.5 μM 和寡霉素 A 为 0.85,寡霉素 B 为 2.3 μM 和 0.82。双向方差分析证实寡霉素 B 在测试的浓度范围内具有显着更强的抑制作用[2]。
寡霉素 A 处理的 Wt(宽型)小鼠肝脏中的 ATP 水平降低。同时,这些小鼠在 LPS/GalN 给药后表现出与 Tg 小鼠一样肝细胞凋亡增强 [3]。在用寡霉素 A 处理后的 Wt 小鼠中检测到 AMPK 的进一步激活。总的来说,这些数据表明肝细胞中 UCP2 的表达可以改变线粒体参数,从而导致 AMPK 激活 [3]。
Cell experiment [1]: | |
Cell lines |
P3 cells |
Preparation Method |
Oxygen consumption was measured at 37 °C in cell culture medium. The oxygen consumption rate was measured under 3 different conditions: phosphorylating state (endogenous respiratory condition), non-phosphorylating state with addition of oligomycin A (50 ng/mL), and uncoupled state by the successive addition of carbonyl cyanide m-chlorophenyl hydrazone (CCCP 0.5 µM) to reach the maximal respiration. |
Reaction Conditions |
50 ng/mL for 3days |
Applications |
Additional oxygen consumption analysis was performed using the Oroboros oxygraph methodology and showed no difference in endogenous oxygen consumption rate at oligomycin A or CCCP, even with a long-term DCA treatment (3 days) |
Animal experiment [2]: | |
Animal models |
Wt and Tg mice |
Preparation Method |
Oligomycin A (1mg/kg ) was given by i.v. for 2h before lipopolysaccharide (LPS) and galactosamine (GalN) treatment |
Dosage form |
intravenous injection (i.v.), 1mg/kg, |
Applications |
Wt mice treated with oligomycin A have decreased ATP levels in the liver. Concomitantly, these mice showed an enhanced apoptosis in hepatocytes as Tg mice after LPS/GalN administration. |
References: [1]: Larrieu, CM; Storevik, S, et al. Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development. 2022. Cancers,14(15). DOI: 10.3390/cancers14153769 |
Cas No. | 579-13-5 | SDF | |
别名 | 寡霉素A; MCH 32 | ||
化学名 | 4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione | ||
Canonical SMILES | CCC1CCC2C(C(C(C3(O2)CCC(C(O3)CC(C)O)C)C)OC(=O)C=CC(C(C(C(=O)C(C(C(C(=O)C(C(C(CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C | ||
分子式 | C45H74O11 | 分子量 | 791.06 |
溶解度 | ≥ 9.9mg/mL in DMSO, ≥ 17.43 mg/mL in EtOH | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.2641 mL | 6.3206 mL | 12.6413 mL |
5 mM | 0.2528 mL | 1.2641 mL | 2.5283 mL |
10 mM | 0.1264 mL | 0.6321 mL | 1.2641 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet